Friday, 8 May 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 8 May 2026
Ascott 1
Ascott 1
Novo's obesity pill hits the TGA

Sales of Novo Nordisk's obesity pill has broken records in the US since launching in January and now its heading to Australia setting the stage for new turf war with Lilly which submitted its own oral GLP-1 for evaluation to the regulator four months ago.

Company snaps up ex-MA exec
After almost five years with Medicines Australia, this senior executive has returned to a Big Pharma role
TODAY
Lilly unveils Vivid health vision
To mark its 150th Anniversary, Lilly Australia has entered an industry-first partnership with the iconic Vivid Sydney light show
TODAY
Medscape
Medscape
$135M market under threat
Exclusivity of four drugs is at risk after a judge allowed the patent term extension protecting them to be challenged
7 May
Aussie class action targets pharma
Law firm continues to assess a "significant number" of enquiries and registrations from people who have used these drugs
6 May
Look who's opening a US office
With growing demand from global pharma for its AI commercialisation platform, this Aussie company is setting up in Boston
6 May
Lilly GM confirms drug launch
Newly approved treatment soon to roll out on private script with Aussie boss acknowledging the "significant challenges" in securing subsidy
5 May
HPG
HPG
Latest Jobs
Industry's 'Most Influential' named
A single Big Pharma has made this year's prestigious TIME100 Most Influential Companies list for a first-to-market win
7 May
Sweet upside for obesity drugs
Bracing for fallout from booming GLP-1 uptake, chocolate manufacturers have instead been delivered a surprise windfall
7 May
Troubled drug faces new drama
After 8 deaths the FDA is now investigating whether data for a major drug was manipulated, and the TGA is paying attention
7 May
Industry's global jobs purge ongoing
While Australia is in the clear, the one-time darling of the pandemic plus two other companies trim their OS workforces
7 May
Who's hit a 25-year milestone?
An idea jotted on the back of a cafe napkin plus a healthy dose of ambition, has seen this company grow into a great Aussie success story
6 May
Bridge Program spans a decade
Collaboration between Australian pharma companies, universities and industry affiliates has celebrated its 10th year
6 May
Board wipeout hits local company
In less than a month an activist investor has won the resignation of a CEO and changed the entire board of this company
6 May
What happened to the PBS in Q1?
There was a significant drop in PBS reimbursements during Q1, but the Department couldn't offer a definitive explanation
5 May
Finally... CAR T funded after five years
Fourth CAR T-cell therapy funded in Australia - and the first for multiple myeloma - marking almost 1200 days since it was first submitted
5 May
Sandoz wins consensus on biosims
Stakeholders are united on what needs to be done to increase the uptake of biosims starting with helping the patient hip pocket
5 May
PBS increase to strain Budget
Govt foreshadows that increased spending on subsidising pharmaceuticals will be the third greatest pressure on the Budget
5 May
Why pharma new hires are quitting
Onboarding at Aussie pharma companies is failing to create emotional attachment to work driving new hires to quit
4 May
Who's made a move to new digs?
While marking a milestone in Australia, this pharma is focused on the future with a long-term commitment to collaboration and innovation
4 May
Aussie discovery goes commercial
First-in-class drug developed from local research has been TGA approved, with the sponsor "exploring" PBS reimbursement
4 May
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.